Tech Licensing
In USA, MyGenostics is the third company that owns the patent of gene enrichment technology and the only one in China. Therefore, MyGenostics is able to develop different types of Gene Enrichment kits that applied for scientific research and clinical diagnosis. The main profit mode of MyGenostics is to charge service fees for targeted gene sequencing from scientific researchers and patients.
.png)
MyGenostics has successfully obtained patents for 6 gene enrichment kits which can be applied to clinics including:
.png)